Thanh Van

Thanh Van is an expert in clinical trials. Thanh Van leads clinical operations at Viking Therapeutics, managing global Phase I–III trials across oncology, metabolic diseases, and cell and gene therapy, overseeing the full trial lifecycle from IND submissions through regulatory readouts. With 14 years of experience spanning academic, pharma, and biotech settings, Thanh Van specializes in First-in-Human and pivotal studies, focusing on timeline management, cross-functional team leadership, and ensuring regulatory readiness under GCP and ICH standards. Their expertise is grounded in their published work and commercial leadership in Clinical Operations, Clinical Trial Management, Regulatory Affairs.